Search

Displaying results 3001 - 3010 of 4188 in total
  1. Drug

    Menatetrenone

    go.drugbank.com/drugs/DB12148
    Investigational

    Menatetrenone has been used in trials studying the treatment of Diabetes, Osteoporosis, Prediabetic State, and Hepatocellular Carcinoma.

  2. Drug

    CP-866087

    go.drugbank.com/drugs/DB12196
    Investigational

    CP-866,087 has been used in trials studying the treatment of Obesity, Alcoholism, and Sexual Dysfunction, Physiological.

  3. Drug

    CP-601927

    go.drugbank.com/drugs/DB12244
    Investigational

    CP-601,927 has been used in trials studying the basic science and treatment of Major Depressive Disorder.

  4. Drug

    Cipargamin

    go.drugbank.com/drugs/DB12306
    Investigational

    Cipargamin has been used in trials studying the treatment of Malaria, Cure Rate, and Plasmodium Falciparum Malaria.

  5. Drug

    Blosozumab

    go.drugbank.com/drugs/DB12560
    Investigational

    Blosozumab has been used in trials studying the basic science and treatment of Osteoporosis and Osteoporosis, Postmenopausal.

  6. Drug

    PSI-352938

    go.drugbank.com/drugs/DB12896
    Investigational

    PSI-352938 has been used in trials studying the treatment of Hepatitis C and Hepatitis C, Chronic.

  7. Drug

    Aminaphthone

    go.drugbank.com/drugs/DB13039
    Investigational

    Aminaftone has been investigated for the treatment of Cockett Syndrome, May-Thurner Syndrome, and Iliac Vein Obstruction.

  8. Drug

    Pifusertib

    go.drugbank.com/drugs/DB15054
    Investigational

    TAS-117 is under investigation in clinical trial NCT03017521 (K-BASKET, TAS-117, PI3K/AKT Gene Aberration).

  9. Drug

    TSHA-102

    go.drugbank.com/drugs/DB18599
    Investigational

    TSHA-102 is a recombinant serotype 9 adeno-associated virus encoding a codon-optimized human MECP2 gene.

  10. Drug

    Setmelanotide

    go.drugbank.com/drugs/DB11700
    ApprovedInvestigational

    Setmelanotide is the first available treatment for patients with pro-opiomelanocortin, proprotein subilisin/kexin type 1, or leptin deficiencies. It is an agonist of the melanocortin 4 receptor. Earlier attempts at agonizing MC4R (such a...